GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | ICAM1 | decreases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in decreased expression of ICAM1 mRNA | PMID:20471514 | ICAM1 | increases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in increased expression of ICAM1; Arsenic Trioxide results in increased expression of ICAM1 mRNA; Arsenic Trioxide results in increased expression of ICAM1 protein | PMID:12083632 PMID:18055984 PMID:27750169 | ICAM1 | multiple interactions | EXP | | 6480464 | CTD | [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ICAM1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ICAM1 mRNA; AG 1879 promotes the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of ICAM1 protein]]; Arsenic Trioxide promotes the reaction [AG 1879 results in increased expression of ICAM1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of ICAM1 protein] | PMID:15894607 PMID:23864846 PMID:24953245 PMID:25913414 | ICAM1 | increases expression | ISO | Icam1 (Mus musculus) | 6480464 | CTD | Arsenic Trioxide results in increased expression of ICAM1 mRNA | PMID:15073043 | |
Go Back to source page | Continue to Ontology report |